The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.50
Bid: 47.15
Ask: 47.55
Change: 0.00 (0.00%)
Spread: 0.40 (0.848%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 47.50
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

24 Aug 2020 07:00

RNS Number : 9427W
Old Mutual Limited
24 August 2020
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

("Old Mutual" or "Company" or "Group")

 

Ref 29/20

24 August 2020

 

TRADING STATEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020.

 

Shareholders are advised that Old Mutual Limited is currently in the process of finalising its interim results for the six months ended 30 June 2020 ("current period"). This trading statement provides an indication of a range for Headline Earnings per ordinary share (HEPS) and earnings attributable to equity holders of the Group per ordinary share (EPS) in terms of paragraph 3.4(b) of the JSE Limited Listings Requirements compared to the six months ended 30 June 2019 ("comparative period"). The Group's interim results will be released on the Stock Exchange News Service of the JSE Limited on Tuesday, 1 September 2020.

 

Further to our previous communication to shareholders on the 29 May 2020, the COVID-19 pandemic continues to have an unprecedented impact on our business, our lives and how we work and interact. Government enforced restrictions to control the spread of COVID-19 in most geographies we operate in have dramatically reduced the level of economic activity during the first half of 2020 and negatively impacted growth forecasts for the remainder of the year. In this challenging environment we adapted to this new normal by leveraging our digital capability to enable most of our employees and certain of our advisers to work remotely.

 

New business sales volumes were negatively impacted, as most of our tied advisers were unable to sell during the lockdown period due to the partial closure of the branch network and lack of access to customers' homes, worksites and branches. Although lockdown restrictions have been eased, and economic activity has somewhat resumed, sales levels remain below prior year levels. This impact was most severe in the Mass and Foundation Cluster, where sales volumes were too low to cover the largely fixed initial expenses and this resulted in negative Value of New Business for H1 2020 for this segment.

 

Although local and global equity markets have recovered in the second quarter, the JSE SWIX was down 8% at the end of June 2020 and average equity market levels were 10% lower than the prior year. During the second quarter we saw credit spreads widening by between 50bps and 100bps, more than increases in previous market crises.

 

Throughout the period, in this tough economic environment, our solvency capital has remained strong. At the end of June 2020, the solvency ratio was 182% for the Group and 208% for OMLACSA. This demonstrates the capital strength and resilience of our Group to withstand periods of prolonged market stresses and positions us well to take advantage of growth opportunities as they arise.

 

The significant deterioration in the operating environment compared to the comparative period has however negatively impacted our earnings. While there is still much uncertainty around the pandemic and the impact that it will have on experience, we have raised short term provisions in anticipation of worsening mortality, morbidity and persistency experience in the second half of 2020. These reserves are intended to allow for expected short term variances to our long term assumptions.

 

Weaker growth forecasts and higher observed credit spreads have led to notable unrealised mark to market losses in the first half of the year in our unlisted equity and credit portfolios in Specialised Finance, although we believe the quality of our credit book remains high. As these are unrealised they could reverse in future periods as market conditions recover. We have also increased our provisions for expected credit losses in Old Mutual Finance in recognition of declining GDP forecasts, and the anticipated impact of this on future credit losses.

 

There was an increase in business interruption (BI) claims in Old Mutual Insure during the second quarter. We also made a decision to offer commercial settlements to certain qualifying Small, Medium and Micro Enterprise (SMME) customers to enable them to continue operating.

 

Taking into account the operating environment and factors outlined above shareholders are advised that the Group's key profit measures are expected to fall within the ranges outlined below:

 

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

30 June 2020

 

 

30 June 2019

Results from Operations

(61%) to (71%)

1,760 - 1,308

4,512

Adjusted Headline Earnings

(62%) to (72%)

1,980 - 1,459

5,211

AHEPS (cents)¹

(60%) to (70%)

43.7 - 32.7

109.1

1AHEPS defined as Adjusted Headline Earnings divided by WANS adjusted to reflect the Group's BBE shares and shares held in policyholder and consolidated investment funds.

 

The notable decrease in the GDP growth for South Africa and increased uncertainty around future cashflow projections is expected to result in the recognition of material impairments in respect of the carrying value of our investment in Nedbank and the goodwill related to our investment in Old Mutual Finance. These impairments are recognised in the IFRS income statement, however, are not recognised in Headline Earnings as this is an explicit adjusting item in accordance with the JSE Circular. Accordingly they are also not recognised in Adjusted Headline Earnings (AHE).

 

Headline earnings is higher than AHE, as AHE excludes the results related to the operations of Residual plc and Zimbabwe and the adjustment in respect of investment return for group equity and debt instruments held in life funds, all of which were positive in H1 2020.

 

Taking into account the decrease in operating earnings and the significant impairments outlined above shareholders are advised that HEPS and Basic EPS are expected to fall within the ranges outlined below:

 

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated 30 June 2020

 

 

30 June 2019

Headline Earnings

(23%) to (33%)

4,507 - 3,922

5,854

HEPS (cents)

(20%) to (30%)

102.5 - 89.7

128.1

IFRS profit after tax attributable to equity holders of the parent

Greater than (100%)

 (5,621) - (6,745)

5,817

Basic EPS (cents)

Greater than (100%)

(128.5) - (154.2)

127.3

 

 

The financial information in this trading statement is the responsibility of the Old Mutual Limited Board of Directors and has not been reviewed or reported on by the Group's external auditors.

 

 

Sandton

 

Sponsors

JSE

Merrill Lynch South Africa (Pty) Limited

Namibia

PSG Wealth Management (Namibia) (Proprietary) Limited

Zimbabwe

Imara Capital Zimbabwe plc

Malawi

Stockbrokers Malawi Limited

 

Enquiries

Investor Relations

Sizwe Ndlovu

Head of Investor Relations

T: +27 (0)11 217 1163

E: tndlovu6@oldmutual.com

Tokelo Mulaudzi

Investor Relations Manager

T: +27 (0)11 217 1042

tmulaudzi3@oldmutual.com

Communications

Tabby Tsengiwe

Head of Communications

T: +27 (11) 217 1953

M: +27 (0)60 547 4947

E: ttsengiwe@oldmutual.com

 

Notes to Editors

 

About Old Mutual Limited

 

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key markets segments in 14 countries. Old Mutual's primary operations are in South Africa and the rest of Africa, and it has a niche business in Asia. With over 175 years of heritage across sub-Saharan Africa, we are a crucial part of the communities we serve and broader society on the continent.

 

For further information on Old Mutual, and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSSVRROUWURR
Date   Source Headline
17th Mar 20233:15 pmRNSDealings in securities on behalf of share trusts
17th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
16th Mar 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
15th Mar 202312:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20237:00 amRNSFinal Results
10th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
9th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
8th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
3rd Mar 202310:00 amRNSForm 8.3 - [Mediclinic International plc]
2nd Mar 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
24th Feb 20237:00 amRNSVoluntary Trading Statement
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding Correction
22nd Feb 20233:30 pmRNSDirector/PDMR Shareholding
7th Feb 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
3rd Feb 20231:00 pmRNSForm 8.3 - [Mediclinic International plc]
27th Jan 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
10th Jan 202311:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Jan 202312:00 pmRNSForm 8.3 - Mediclinic International plc
21st Dec 20221:00 pmRNSForm 8.3 - [Mediclinic International plc]
16th Dec 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 20221:50 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 202211:30 amRNSForm 8.3 - Micro Focus International plc
30th Nov 202212:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Nov 20227:00 amRNSVoluntary Operating Update
21st Nov 20223:00 pmRNSImplementation of the Bula Tsela transaction
18th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
17th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
16th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
11th Nov 20221:30 pmRNSForm 8.3 - Mediclinic International plc
4th Nov 20223:10 pmRNSOld Mutual Bula Tsela Transaction
20th Oct 202212:00 pmRNSForm 8.3 - Mediclinic International plc
14th Oct 202211:00 amRNSForm 8.3 - Mediclinic International plc
13th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
12th Oct 20221:00 pmRNSForm 8.3 - Mediclinic International plc
6th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:00 pmRNSDirectorate Change
23rd Sep 20223:00 pmRNSForm 8.3 - Mediclinic International plc
6th Sep 202210:30 amRNSDirector/PDMR Shareholding
6th Sep 20229:30 amRNSInterim Dividend Currency Equivalents
30th Aug 20227:00 amRNSUnaudited Interim Results and Dividend Declaration
19th Aug 20222:00 pmRNSForm 8.3 - Mediclinic International plc
16th Aug 202212:40 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:30 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:00 pmRNSResults of shareholder voting at GM
11th Aug 20227:00 amRNSTrading Statement
4th Aug 202212:00 pmRNSForm 8.3 - Mediclinic International plc
27th Jul 20222:30 pmRNSForm 8.3 - Mediclinic International plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.